Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
These data support the importance of TPMT genotyping and suggest that thiopurine TDM generates supplementary information and should be performed for all patients.
Authors
- Vladimir Trkulja (ORCID: https://orcid.org/0000-0002-0968-1194)
- Silvija Čuković‐Čavka (ORCID: https://orcid.org/0000-0002-6176-7948)
- Kristina Dukić
- Nada Božina (ORCID: https://orcid.org/0000-0001-6016-1699)
- Mila Lovrić
- Lana Ganoci (ORCID: https://orcid.org/0000-0003-3898-4554)
Institutions
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1097/ftd.0000000000001327
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00